Changzhou Qianhong Bio-pharma Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Changzhou Qianhong Bio-pharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. (NCT07396337) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2026-01-19 |
| Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia (NCT06532058) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2023-08-10 |
| Study to Assess PK, Safety and Tolerability in Healthy Subjects (NCT06380699) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2023-03-16 |
| Study to Assess PK, Safety and Tolerability Early in Healthy Subjects (NCT06388772) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2021-07-05 |
Track Changzhou Qianhong Bio-pharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.